Organogenesis Holdings Inc
NASDAQ:ORGO
Organogenesis Holdings Inc
NASDAQ:ORGO
Price:
3.79
USD
1.61%
Market Closed
Market Cap:
$481m
Relative Value
The Relative Value of one
ORGO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.79 USD,
Organogenesis Holdings Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ORGO Relative Value
HIDDEN
Multiples Across Competitors
ORGO Competitors Multiples
Organogenesis Holdings Inc Competitors
Organogenesis Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Organogenesis Holdings Inc
NASDAQ:ORGO
|
481m USD | 1 | -36.1 | 22.2 | 491.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
411.5B USD | 6.9 | 175.3 | 16.9 | 24 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
201.1B USD | 5.5 | 26.1 | 14.9 | 14.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
192.5B USD | 6.5 | 22.6 | 15.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.8B USD | 10.1 | 30.6 | 23.4 | 24.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD | 5.8 | 18.6 | 14.2 | 16.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 14.3 | 33.7 | 57.9 | 59.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
74.8B AUD | 3.3 | 17.2 | 11.7 | 14.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
